Catheter Ablation Clinical Trial
— FASD-HPOfficial title:
High-Power Short-Duration Radiofrequency Ablation in Patients With Typical Atrial Flutter
The aim of cavotricuspid isthmus (CTI) dependent flutter ablation is the bidirectional conduction block of CTI. The probability of achieving a permanent bidirectional block at the CTI depends, mainly, on the ablation energy applied and the quality of the obtained lesion. Among the factors that determine the lesion's quality those which have the bigger impact are catheter stability, contact force, power and duration of energy application and the temperature reached at depth.This is a multicenter 1:1 randomized, blinded (open for the operator) study. Two CTI ablation strategies are compared: 1) conventional treatment branch which consists of individual 25-40 W applications of unlimited duration until achieving in each application the minimum value of one of the currently accepted and used lesion markers (Ablation Index >500 at the anterior half of the CTI and >400 at the posterior half with de CARTO 3 system; 2) experimental treatment branch consistent of CTI block using individual high power (90W) short duration (4 seconds) point-by-point applications. The main objective of this study is assessing the non-inferiority of the efficacy and safety of high-power short-duration ablation in patients undergoing typical atrial flutter ablation. Secondary objectives include the comparison of total radiofrequency time, number of applications, number of steam pops, percentage of reconnections, procedure duration, pain during the procedure and time to atrial flutter recurrence.
Status | Recruiting |
Enrollment | 120 |
Est. completion date | April 2025 |
Est. primary completion date | April 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients with cavotricuspid isthmus dependent flutter referred to ablation - Patients clinically and hemodynamically stable. - Patients who give informed consent. Exclusion Criteria: - Refusal to participate in the register or inability to understand the informed consent. - Age under 18. - Patients who have already undergone previous flutter ablation procedures. |
Country | Name | City | State |
---|---|---|---|
Spain | Hospital General Doctor Balmis Alicante | Alicante | A |
Lead Sponsor | Collaborator |
---|---|
Jose Luis Ibañez Criado |
Spain,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Safety primary outcome: incidence of procedure-related complications. | Number of procedure-related complications from the time of the ablation until the last follow-up visit. | One year | |
Primary | Efficacy primary outcome: typical atrial flutter recurrence. | Incidence of typical atrial flutter recurrence during a one-year follow-up period. To be considered clinically relevant the recurrence must be documented by a full EKG made because of patients' symptoms or any typical atrial flutter detected by an EKG, 24h Holter-EKG or events-monitoring device that will be performed at least at a 6 months and 12 months follow-up visits. | One year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03593486 -
Low-Level EMF Stimulation for Paroxysmal Atrial Fibrillation
|
N/A | |
Terminated |
NCT01546207 -
Stepwise Approach To sUbstrate Modification for Ventricular Tachycardia
|
N/A | |
Active, not recruiting |
NCT06124690 -
Persistent Atrial Fibrillation Without the Evidence of Low-voltage Areas
|
N/A | |
Recruiting |
NCT05251545 -
Randomized Trial: High Power Short Duration Versus Ablation Index
|
N/A | |
Not yet recruiting |
NCT04780438 -
Dapagliflozin to Prevent Atrial Fibrillation Recurrence After Transcatheter Pulmonary Venous Isolation.
|
Early Phase 1 | |
Active, not recruiting |
NCT03695484 -
Registry Evaluating AF Ablation Techniques
|
||
Not yet recruiting |
NCT05565183 -
Combined Study of ATrial Strain and Voltage by High Density Mapping in Young Patients With Atrial Fibrillation.
|
N/A | |
Recruiting |
NCT06160076 -
Inflammatory Response Following " Pulsed Field Ablation " vs. Radiofrequency Ablation-2
|
||
Not yet recruiting |
NCT05575544 -
Electroacupuncture Intervention in Catheter Ablation of Atrial Fibrillation
|
N/A | |
Recruiting |
NCT04678258 -
Zero Fluoroscopy Voltage Guided vs. Linear CTI Ablation
|
N/A | |
Active, not recruiting |
NCT01630031 -
Contact Force Sensing and Pulmonary Vein Isolation
|
N/A | |
Completed |
NCT04896424 -
Vagal Response and Cardiac Autonomic Modulation. Insides From Cryoballoon Ablation
|
N/A | |
Completed |
NCT04906720 -
Post-Ablation Pericarditis Reduction Study
|
Phase 2 | |
Not yet recruiting |
NCT05273645 -
PrOgnosis Following Esophageal fisTula formaTion in Pts Undergoing cathetER Ablation for AF Study
|
||
Completed |
NCT03140631 -
Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
|
Phase 4 | |
Active, not recruiting |
NCT03514693 -
Efficacy of Pulmonary Vein Isolation Alone in Patients With Persistent Atrial Fibrillation
|
N/A | |
Recruiting |
NCT03832959 -
Esophageal Damage Protection During Pulmonary Vein Ablation. Pilot Study.
|
N/A | |
Not yet recruiting |
NCT05716581 -
Prognostic Factors for Ablation of Atrial Fibrillation
|
||
Active, not recruiting |
NCT04405258 -
Left Atrial Posterior Wall Additional Isolation for Persistent Atrial Fibrillation Trial
|
Phase 4 | |
Completed |
NCT03340922 -
MANual vs. automatIC Local Activation Time Annotation for Guiding Premature Ventricular Complex Ablation
|
Phase 4 |